Afya Ltd (AFYA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Afya Ltd stock $30.27, price $10.09, upside +200.0%, quality 69 out of 100. Rating: strongly undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Afya Ltd
AFYA · USCheap (67% below fair value), solid company and rising price: meets all 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range $8.53 – $21.27 · fair‑value band $18.27 – $39.36 · the $10.09 price screens below the $30.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Afya is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions.
Show moreShow less
The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy.
The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students.
The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms.
This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others.
The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
Stock analysis
Afya Ltd (AFYA) currently trades at $10.09, while our model-based Fair Value estimate is $30.27, implying the stock looks roughly 67% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $63.20 per share, and 20 of the 22 models we run sit above the $10.09 price.
Bear case: the Economic Profit group reads lowest at $22.85, and 2 of the 22 models stay below the price. Data coverage for this calculation is low.
Scenario range: $18.27 (bear) to $39.36 (bull), the price of $10.09 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Afya Ltd reported revenue of R$3.6B in FY2025 versus R$1.7B in FY2021, a compound +20.5%/yr. Reported net income was R$738M in FY2025, compounding +34.8%/yr from FY2021.
Key figures
Market cap $901M Small · P/E ratio 6.3 · P/S ratio 1.28 · EPS (TTM) $1.64 · Dividend yield 6.5% · Net margin 20.4% · Return on equity 16.7% · Return on assets (EBIT) 10.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 74 out of 100 (low confidence).
What moves the price
The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.
The share trades about 36% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 30% fair-value upside, at 200%, AFYA screens cheaper than that median.
Fair Value models
All 22 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, 3 officers or directors sold shares worth $1.4M and none bought.
- SaleSantos Welder FerreiraController2× since Apr 17, 2026: 7,486 shares, avg. $14.45$108,209Oct 5, 2026
- SaleLelio de Souza JuniorVice President4× since Apr 7, 2026: 120,777 shares, avg. $14.93$1.8MJul 1, 2026
- SaleGomiero Mirella BasolliVice President10,000 shares at $14.80$148,000Jun 26, 2026
- SaleDe Sousa Anibal Jose GrifoVP Legal, Comp., & Gov Rel.2× since Apr 7, 2026: 19,000 shares, avg. $15.36$291,770Apr 13, 2026
- SaleLuis Andre Carpintero BlancoChief Financial Officer10,000 shares at $15.20$152,000Apr 8, 2026
- SaleVirgilio Deloy Capobianco GibbonChief Executive Officer4× since Mar 25, 2026: 50,000 shares, avg. $14.98$748,835Apr 6, 2026
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
Watch AFYA, get fair value alerts →
Compare Afya Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Education & Training Services · 114 stocks
Valuation Multiplesvs Education & Training Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Consumer Discretionary sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Education & Training Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stride, Inc LRN | $76.55 | $171.72 | +124% | vs AFYA |
| New Oriental Education & Technology Group 9901 | HK$41.88 | HK$64.56 | +54% | vs AFYA |
| Perdoceo Education Corporation PRDO | $28.95 | $41.20 | +42% | vs AFYA |
| Covista Inc CVSA | $117.74 | $152.79 | +30% | vs AFYA |
| Grand Canyon Education, Inc LOPE | $119.31 | $154.63 | +30% | vs AFYA |
| Laureate Education, Inc LAUR | $34.54 | $42.74 | +24% | vs AFYA |
| East Buy Holding 1797 | HK$29.60 | HK$31.39 | +6% | vs AFYA |
| Youdao, Inc DAO | $19.55 | $18.57 | −5% | vs AFYA |
| McGraw Hill, Inc MH | $11.89 | $8.95 | −25% | vs AFYA |
| Physicswallah Limited PWL | ₹129.45 | ₹31.71 | −76% | vs AFYA |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Afya Ltd (AFYA) overvalued or undervalued?
What is the fair value of AFYA?
What is the quality score of AFYA?
What is the price target for Afya Ltd (AFYA)?
What is the Afya Ltd stock forecast for 2026?
What is the revenue of Afya Ltd (AFYA)?
Does Afya Ltd pay a dividend?
How much is the dividend of Afya Ltd (AFYA) and when is the ex-dividend date?
What is the intrinsic value of Afya Ltd (AFYA)?
Is Afya Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of AFYA?
How much is Afya Ltd worth?
What do the bullish and bearish scenarios say about AFYA?
What is the P/E ratio of AFYA?
How solid is the balance sheet of Afya Ltd (AFYA)?
How far is AFYA from its 52-week high?
Which stocks are comparable to Afya Ltd?
Is Afya Ltd stock attractive at the current price?
How is the fair value of AFYA calculated?
Is it still worth investing in stocks now?
What is the share price of Afya Ltd (AFYA)?
What should I pay attention to with Afya Ltd right now?
Key figures of Afya Ltd
How large is the market capitalisation of Afya Ltd (AFYA)?
What is the P/S ratio of Afya Ltd (AFYA)?
What are the earnings per share of Afya Ltd (AFYA)?
What is the dividend yield of Afya Ltd (AFYA)?
What is the net margin of Afya Ltd (AFYA)?
What is the return on equity of Afya Ltd (AFYA)?
What is the EBIT return on assets of Afya Ltd (AFYA)?
What is the operating margin of Afya Ltd (AFYA)?
How fast is revenue growing at Afya Ltd (AFYA)?
How fast are earnings growing at Afya Ltd (AFYA)?
How much free cash flow does Afya Ltd (AFYA) generate?
How much net debt does Afya Ltd (AFYA) carry?
Watch Afya Ltd in the live analysis
One click puts Afya Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.